Neurotrope, Inc. Common
NTRP
NTRP was delisted on the 1st of December, 2020.
27 hedge funds and large institutions have $9M invested in Neurotrope, Inc. Common in 2017 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 5 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
220% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 5
82% more call options, than puts
Call options by funds: $837K | Put options by funds: $460K
69% more funds holding
Funds holding: 16 → 27 (+11)
16% more capital invested
Capital invested by funds: $7.78M → $9M (+$1.23M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.08M |
| 2 |
Stifel Financial
St. Louis,
Missouri
|
+$861K |
| 3 |
OCMI
Oaktop Capital Management II
Chatham,
New Jersey
|
+$768K |
| 4 |
CC
Cannell & Co
New York
|
+$662K |
| 5 |
Eagle Capital Management (New York)
New York
|
+$638K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$867K |
| 2 |
BFM
Boston Financial Management
Boston,
Massachusetts
|
-$837K |
| 3 |
PP
Peconic Partners
New York
|
-$191K |
| 4 |
TCM
Tanaka Capital Management
New York
|
-$115K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$106K |
NTRP Hedge Fund Activity: Q2 2017 in Review
27 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Neurotrope, Inc. Common (NTRP) for Q2 2017, worth a combined $9M — up 16% from $7.78M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new NTRP positions and 5 closed out — a net gain of 11 holders — while 7 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $2.08M. The largest seller was Knoll Capital Management, exiting entirely with an estimated $867K sold.
- 27 institutional investors held Neurotrope, Inc. Common (NTRP) as of Q2 2017, up from 16 in Q1 2017.
- Funds reported $9M of Neurotrope, Inc. Common stock for Q2 2017, up 16% quarter-over-quarter.
- 16 funds opened new Neurotrope, Inc. Common positions in Q2 2017 and 5 closed out, a net change of +11 holders.
- The largest Neurotrope, Inc. Common buyer in Q2 2017 was Vanguard Group, an estimated $2.08M added.
- The largest Neurotrope, Inc. Common seller in Q2 2017 was Knoll Capital Management, an estimated $867K sold.
Based on aggregated 13F filings for Q2 2017.